Evidence map›Paper›PMID 30190568›Full record

ArticleScientific reports2018

Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in cellulo.

Lucia Cardo, Isabel Nawroth, Peter J Cail, Jane A McKeating, Michael J Hannon

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 33 citations in OpenAlex.

  1. Interactions of elongated dinuclear metallo-cylinders with DNA three-way and four-way junctions.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2025
    Article
  2. Article
  3. Switching on Supramolecular DNA Junction Binding Using a Human Enzyme.Angewandte Chemie (International ed. in English) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cavity-Containing [FeFrontiers in chemistry · 2021
    Article
  10. FeJournal of the American Chemical Society · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lucia CardoSchool of Chemistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Isabel NawrothInstitute of Immunology and Immunotherapy Centre for Human Virology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Peter J CailSchool of Chemistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Jane A McKeatingNuffield Department of Medicine, Oxford University, Oxford, OX3 7BN, UK. jane.mckeating@ndm.ox.ac.uk.
Michael J HannonSchool of Chemistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. m.j.hannon@bham.ac.uk.ORCID 0000-0002-5797-6747
University of Birmingham · GBUniversity of Oxford · GB

Funding

Medical Research Council G0801976Medical Research Council G1100247Medical Research Council MC_PC_16056Medical Research Council MR/K01532X/1Wellcome TrustWellcome Trust 200838/Z/16/Z
6 · The paper itself

Abstract

Shape-selective recognition of nucleic acid structures by supramolecular drugs offers the potential to treat disease. The Trans Activation Response (TAR) region is a region of high secondary structure within the human immunodeficiency virus-1 (HIV-1) RNA that complexes with the virus-encoded Transactivator protein (TAT) and regulates viral transcription. Herein, we explore different metallo-supramolecular triple stranded helicates (cylinders) that target the TAR bulge motif and inhibit the formation of TAR-TAT complexes and HIV infection. Cylinders that incorporate Ni(II) and Ru(II) showed the most potent anti-viral activity with limited evidence of cellular cytotoxicity. These metallo-supramolecular compounds provide an exciting avenue for developing a new class of anti-viral agents.

Indexed as

Antiviral AgentsCoordination ComplexesHIV-1NickelRegulatory Sequences, Ribonucleic AcidRNA, ViralRubidiumtat Gene Products, Human Immunodeficiency VirusCell LineHumansAntiviral AgentsCoordination ComplexesNickelRegulatory Sequences, Ribonucleic AcidRNA, ViralRubidiumtat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID30190568
PMCPMC6127258
OpenAlexW2888908625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.